Member Detail - DF/HCC

Dr. Gregory Cote, MD

Claim this profile

Massachusetts General Hospital

Studies Cancer
Studies Solid Tumors
19 reported clinical trials
27 drugs studied

Area of expertise

1

Cancer

Gregory Cote, MD has run 8 trials for Cancer. Some of their research focus areas include:

Stage IV
Stage III
EGFR positive
2

Solid Tumors

Gregory Cote, MD has run 6 trials for Solid Tumors. Some of their research focus areas include:

Stage IV
Stage III
TAZ-CAMTA1 positive

Affiliated Hospitals

Image of trial facility.

Massachusetts General Hospital

Image of trial facility.

Dana-Farber - Harvard Cancer Center LAO

Clinical Trials Gregory Cote, MD is currently running

More about Gregory Cote, MD

Clinical Trial Related

8 years of experience running clinical trials · Led 19 trials as a Principal Investigator · 1 Active Clinical Trial

Treatments Gregory Cote, MD has experience with

  • Lurbinectedin
  • Nivolumab
  • Doxorubicin
  • Eribulin
  • Peposertib
  • Tuvusertib

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Gregory Cote, MD specialize in?

Is Gregory Cote, MD currently recruiting for clinical trials?

Are there any treatments that Gregory Cote, MD has studied deeply?

What is the best way to schedule an appointment with Gregory Cote, MD?

What is the office address of Gregory Cote, MD?

Is there any support for travel costs?